Xiaoxue Li

3PUBLICATIONS
46CO-AUTHORS
Gene and molecular therapyMolecular targetsAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.

Michael I Barbato, Amy K Barone, Stephanie L Aungst

|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.

Sonia Singh, Diana Bradford, Somak Chatterjee

|Aug 25, 2023
FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum.

Sonia Singh, Diana Bradford, Xiaoxue Li

Pageof 1